Syndax Pharmaceuticals SNDX
NASDAQ SNDX
$9.62 +0.13 (+1.37%)
As of: Nov 11, 2026 · 11:10 AM EST

Syndax Pharmaceuticals (SNDX) Shares Outstanding (Diluted) (2019 - 2026)

Updated

Syndax Pharmaceuticals (SNDX) recorded Weighted Average Shares Outstanding (Diluted) of 89.79 million in Q3 2026, up 3.7% from 86.62 million a year earlier and up 0.9% from the prior quarter.

Analysis

Syndax Pharmaceuticals (SNDX) Shares Outstanding (Diluted) (2019 - 2026) Analysis & Trends

For FY2025, Syndax Pharmaceuticals reported Weighted Average Shares Outstanding (Diluted) of 86.63 million, up 1.2% from FY2024.

  • Annual Weighted Average Shares Outstanding (Diluted) has increased for six straight years, with a five-year compound annual growth rate of 16.0% (FY2020 to FY2025).
  • Across earlier years, Weighted Average Shares Outstanding (Diluted) came in at 85.62 million in FY2024 (+21.7%), 70.37 million in FY2023 (+15.8%), 60.76 million in FY2022 (+13.3%) and 53.62 million in FY2021 (+29.8%).
  • The Q3 2026 figure is the highest quarterly Weighted Average Shares Outstanding (Diluted) in data going back to Q4 2019.
  • On a year-over-year basis, Weighted Average Shares Outstanding (Diluted) has increased for 24 consecutive quarters, with growth averaging 4.5% over the last eight quarters.
  • Across the past five years, year-over-year growth in Weighted Average Shares Outstanding (Diluted) ran from 1.1% in Q1 2025 to 42.8% in Q1 2022.
  • Per Business Quant, the preceding three quarters came in at 88.99 million (Q2 2026), 88.26 million (Q1 2026) and 86.63 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 893.40 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.45 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 1.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.48 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 1.96 Bn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.56 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 546.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.25 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 5.75 Bn
10 Syndax Pharmaceuticals 854.00 Mn -867.10 Mn 69.30 Mn 89.79 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 89.79 Mn
Jun 30, 2026 88.99 Mn
Mar 31, 2026 88.26 Mn
Dec 31, 2025 86.63 Mn
Sep 30, 2025 86.62 Mn
Jun 30, 2025 86.34 Mn
Mar 31, 2025 86.17 Mn
Dec 31, 2024 85.62 Mn
Sep 30, 2024 85.43 Mn
Jun 30, 2024 85.27 Mn
Mar 31, 2024 85.21 Mn
Dec 31, 2023 70.37 Mn
Sep 30, 2023 69.86 Mn
Jun 30, 2023 69.64 Mn
Mar 31, 2023 69.44 Mn
Dec 31, 2022 60.76 Mn
Sep 30, 2022 60.67 Mn
Jun 30, 2022 60.16 Mn
Mar 31, 2022 58.98 Mn
Dec 31, 2021 53.62 Mn
API Access

Syndax Pharmaceuticals Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=SNDX&period=max&api_key=YOUR_API_KEY